Oppenheimer & Co’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,500
Closed -$18K 1349
2015
Q3
$18K Hold
1,500
﹤0.01% 1332
2015
Q2
$29K Hold
1,500
﹤0.01% 1455
2015
Q1
$27K Sell
1,500
-6,500
-81% -$117K ﹤0.01% 1463
2014
Q4
$147K Sell
8,000
-1,700
-18% -$31.2K ﹤0.01% 1289
2014
Q3
$235K Buy
9,700
+5,630
+138% +$136K 0.01% 1178
2014
Q2
$149K Buy
4,070
+20
+0.5% +$732 ﹤0.01% 1304
2014
Q1
$186K Buy
4,050
+965
+31% +$44.3K 0.01% 1262
2013
Q4
$120K Buy
+3,085
New +$120K ﹤0.01% 1302